Cetrolan 0.25% Injection
Marketer
Mylan Pharmaceuticals Pvt Ltd - A Viatris Company
Salt Composition
Cetrorelix (0.25% w/v)
Overview Cetrolan 0.25% Injection
GnRH antagonist Cetrolan 0.25% Injection aids female infertility treatment by suppressing egg release and preventing premature ovulation. Administered subcutaneously by a healthcare professional, self-injection is strictly prohibited. Home administration guidance will be provided by your doctor or nurse. Dosage frequency is tailored to individual needs and determined by your physician to optimize therapeutic effects; continue treatment as prescribed. Common side effects comprise injection site reactions (erythema, pruritus, irritation), nausea, and emesis. Rotate injection sites (abdominal area) daily to minimize irritation. Report immediately any dizziness, syncope, abdominal pain, or persistent vomiting. Prior to commencing treatment, inform your doctor of any pre-existing hepatic or renal conditions, or breastfeeding status. Disclosure of all other medications is crucial, as interactions may compromise efficacy or alter Cetrolan's action.
Uses of Cetrolan 0.25% Injection
Inability to conceive in women
Major Benefits of Cetrolan 0.25% Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Cetrolan 0.25% Injection:
- Nausea
- Ovarian hyperstimulation syndrome
- Injection site reactions (pain, swelling, redness)
- Itching
- Irritation
- Vomiting
- Lower abdominal pain
How to use Cetrolan 0.25% Injection:
This medication will be administered by your physician or their qualified nurse; self-medication is strictly prohibited.
How Cetrolan 0.25% Injection works:
During infertility treatment in women, premature egg release can occur, yielding eggs unsuitable for fertilization. Cetrolan 0.25% Injection inhibits a key hormone, thereby preventing premature ovarian egg expulsion.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Cetrolan 0.25% Injection requires careful consideration. Seek medical advice before combining them.
PregnancyUNSAFE
Administering Cetrolan 0.25% Injection during pregnancy poses a substantial risk. Pregnant individuals should consult their physician; research in both animal and human subjects indicates considerable adverse consequences for fetal development.
Breast feedingUNSAFE
Administering Cetrolan 0.25% Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from the medication.
DrivingSAFE
Administering Cetrolan 0.25% Injection typically does not impair driving capabilities.
KidneyCAUTION
Patients with kidney impairment should receive Cetrolan 0.25% Injection cautiously, potentially requiring dosage modification. Medical advice is necessary. Cetrolan 0.25% Injection is contraindicated in individuals with severely compromised kidney function.
LiverCAUTION
Patients with liver impairment should receive Cetrolan 0.25% Injection cautiously, potentially requiring a modified dosage. Physician consultation is advised.
What if you forget to take Cetrolan 0.25% Injection :
Omit a Cetrolan 0.25% Injection dose? Seek your physician's advice.
Facts to Know About Cetrolan 0.25% Injection
| Label | Value |
|---|---|
| Chemical Type | Peptide chains |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
| Action Class | GnRH receptor antagonists |
3,018 People bought this recently